Baldwin Wealth Partners
NVCT icon

Baldwin Wealth Partners’s Nuvectis Pharma NVCT Stock Holding History

Baldwin Wealth Partners’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.07M Hold
382,015
– – 0.53% 42
2026
Q2 		$7.03M Buy
382,015
+3,390
+0.9% +$38K 0.46% 53
2026
Q1 		$2.93M Sell
378,625
-11,000
-3% -$94.2K 0.21% 71
2025
Q4 		$2.94M Buy
389,625
+39,164
+11% +$255K 0.19% 72
2025
Q3 		$2.11M Hold
350,461
– – 0.14% 82
2025
Q2 		$2.62M Sell
350,461
-8,000
-2% -$72.5K 0.18% 74
2025
Q1 		$3.5M Buy
358,461
+2,500
+0.7% +$18K 0.25% 64
2024
Q4 		$1.93M Buy
355,961
+181,831
+104% +$1.14M 0.13% 84
2024
Q3 		$1.1M Buy
174,130
+5,500
+3% +$36.2K 0.07% 123
2024
Q2 		$1.07M Buy
168,630
+14,500
+9% +$98.6K 0.08% 100
2024
Q1 		$1.26M Buy
154,130
+12,090
+9% +$103K 0.1% 100
2023
Q4 		$1.18M Buy
142,040
+25,660
+22% +$229K 0.09% 99
2023
Q3 		$1.5M Buy
116,380
+26,319
+29% +$381K 0.13% 91
2023
Q2 		$1.44M Sell
90,061
-53,739
-37% -$858K 0.12% 99
2023
Q1 		$1.89M Buy
143,800
+10,500
+8% +$106K 0.16% 92
2022
Q4 		$1000K Buy
133,300
+300
+0.2% +$2.15K 0.09% 112
2022
Q3 		$943K Buy
133,000
+12,000
+10% +$112K 0.13% 71
2022
Q2 		$1.36M Buy
+121,000
New +$1.5M 0.18% 61

Other funds holding NVCT

Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Baldwin Wealth Partners's NVCT Position: Q3 2026 in Review

Baldwin Wealth Partners held its Nuvectis Pharma (NVCT) position steady in Q3 2026 at 382,015 shares worth $8.07M. The position accounts for 0.53% of the portfolio, ranked #42.

Baldwin Wealth Partners first reported a position in NVCT in Q2 2022 and has held it in 18 quarters since. 19 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • Baldwin Wealth Partners held 382,015 shares of Nuvectis Pharma worth $8.07M as of Q3 2026.
  • Baldwin Wealth Partners left its Nuvectis Pharma share count unchanged in Q3 2026.
  • Nuvectis Pharma made up 0.53% of Baldwin Wealth Partners's portfolio in Q3 2026, its #42 holding.
  • Baldwin Wealth Partners first reported a position in Nuvectis Pharma in Q2 2022 and has held it in 18 quarters since.
  • 19 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Baldwin Wealth Partners's 13F filing for Q3 2026, filed 13 Oct 2026.